Cita APA

D, M., C, G., J, S., G, R., J, P., R, G., . . . group, S. P. (2019). A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.

Citación estilo Chicago

D, Martínez-Cuadrón, et al. A Precision Medicine Test Predicts Clinical Response After Idarubicin and Cytarabine Induction Therapy in AML Patients. 2019.

Cita MLA

D, Martínez-Cuadrón, et al. A Precision Medicine Test Predicts Clinical Response After Idarubicin and Cytarabine Induction Therapy in AML Patients. 2019.